Market Overview

Morgan Stanley Initiates Coverage On El Pollo Loco


Shares of El Pollo Loco (NASDAQ: LOCO) are trading lower in Tuesday's pre-market session. Morgan Stanley analyst Jake Bartlett came out after the quiet period expiration and initiated Loco at Underweight with a $22 price target.

Bartlett feels Loco is richly priced for its growth and that current valuation understates the risks. He makes three different cases for the stock price, highlighted below:

Pollo en Fuego: Bull Case-$38 price target

"For our bull case to unfold, LOCO would have to outperform our expectations on all measures, giving investors confidence in upside to initial growth targets while continuing to out-comp competitors."

Pollo Bueno: Base Case-$22 price target

"Our base case assumes steady execution of the unit growth plan while maintaining healthy (low-to-midsingle) digit comps in the near term."

Pollo Muertos: Bear Case-$13 price target

"Lower-than-expected volumes in new markets like Houston and sharply decelerating comps would signal more limited expansion opportunities, driving sharp
multiple contraction."

Shares of El Pollo Loco traded recently at $31.50, down five percent.

Latest Ratings for LOCO

Nov 2018MaintainsNeutralNeutral
Oct 2018MaintainsBuyBuy
Mar 2018MaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for LOCO
View the Latest Analyst Ratings

Posted-In: Jake Bartlett Morgan StanleyAnalyst Color Price Target Initiation Analyst Ratings


Related Articles (LOCO)

View Comments and Join the Discussion!

Latest Ratings

ROSTMKM PartnersMaintains121.0
BJDeutsche BankMaintains27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Gabelli Downgrades Lexicon Pharmaceuticals To Hold

UPDATE: Elizabeth Arden Posts Wider FQ4 Loss, Shares Tumble